Xencor (NASDAQ: XNCR) revenue
Xencor reported revenue of $125.6m for fiscal 2025, 13.7% more than in fiscal 2024 ($110.5m). Since fiscal 2016 its revenue has grown by 15.2%, an average growth of 1.6% a year.
Xencor's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2017, −57.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $125.6m | +13.7% | −$177.5m | −141.4% |
| 2024 | $110.5m | −36.7% | −$178.4m | −161.5% |
| 2023 | $174.6m | +6.1% | −$132.4m | −75.8% |
| 2022 | $164.6m | −40.2% | −$82.5m | −50.1% |
| 2021 | $275.1m | +124.2% | $43.8m | 15.9% |
| 2020 | $122.7m | −21.7% | −$76.8m | −62.6% |
| 2019 | $156.7m | +285.9% | $13.8m | 8.8% |
| 2018 | $40.6m | −12.0% | −$79.4m | −195.5% |
| 2017 | $46.2m | −57.7% | −$43.1m | −93.4% |
| 2016 | $109.0m | — | $44.0m | 40.4% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Xencor revenue compared with its sector
By revenue for its latest fiscal year, Xencor ranks 273rd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Xencor, 13.7%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 271st | RxSight | $134.5m | −3.9% |
| 272nd | Lifecore Biomedical | $128.9m | 0.5% |
| 273rd | Xencor | $125.6m | 13.7% |
| 274th | Monte Rosa Therapeutics | $123.7m | 63.5% |
| 275th | Gyre Therapeutics | $116.6m | 10.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Xencor
- How much revenue did Xencor make in fiscal 2025?
- Xencor reported revenue of $125.6m for fiscal 2025, compared with $110.5m in fiscal 2024.
- How much has the revenue of Xencor grown?
- Between fiscal 2016 and fiscal 2025 it went from $109.0m to $125.6m: 15.2% more, an average growth of 1.6% a year.
- What was the best year for revenue at Xencor?
- Of its last 10 fiscal years, fiscal 2021, with $275.1m.
- Where does Xencor rank in its sector by revenue?
- It ranks 273rd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Xencor come from?
- From the annual report (Form 10-K) that Xencor files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Xencor files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Xencor: the Xencor page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.